These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2715790)

  • 21. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin.
    Chini B; Mouillac B; Balestre MN; Trumpp-Kallmeyer S; Hoflack J; Hibert M; Andriolo M; Pupier S; Jard S; Barberis C
    FEBS Lett; 1996 Nov; 397(2-3):201-6. PubMed ID: 8955347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
    Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
    J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
    Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
    J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine-, D-arginine-vasopressin, and their inverso analogues in micellar and liposomic models of cell membrane: CD, NMR, and molecular dynamics studies.
    Lubecka EA; Sikorska E; Sobolewski D; Prahl A; Slaninová J; Ciarkowski J
    Eur Biophys J; 2015 Dec; 44(8):727-43. PubMed ID: 26290060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture.
    Beck TR; Hassid A; Dunn MJ
    J Pharmacol Exp Ther; 1980 Oct; 215(1):15-9. PubMed ID: 7452479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens.
    Maggi M; Malozowski S; Kassis S; Guardabasso V; Rodbard D
    Endocrinology; 1987 Mar; 120(3):986-94. PubMed ID: 3026794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladder.
    Mann WA; Stassen F; Huffman W; Kinter LB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):401-6. PubMed ID: 3090234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic actions and interactions of arginine vasopressin, angiotensin-II, and oxytocin on adrenocorticotropin secretion by rat anterior pituitary cells in the microperifusion system.
    Watanabe T; Oki Y; Orth DN
    Endocrinology; 1989 Oct; 125(4):1921-31. PubMed ID: 2551632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.
    Antoni FA; Holmes MC; Makara GB; Kárteszi M; László FA
    Peptides; 1984; 5(3):519-22. PubMed ID: 6089144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vasopressin on the human non-pregnant uterus: studies with analogues of different vasopressor potencies.
    Melin P; Trojnar J; Carlsson AM; Bengtsson B; Akerlund M; Robinson I
    Eur J Pharmacol; 1988 Mar; 148(1):93-9. PubMed ID: 3383999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
    Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
    J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation.
    Schmidt JM; Ohlenschläger O; Rüterjans H; Grzonka Z; Kojro E; Pavo I; Fahrenholz F
    Eur J Biochem; 1991 Oct; 201(2):355-71. PubMed ID: 1935933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
    Manning M; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excitation of neurones in the rat paraventricular nucleus in vitro by vasopressin and oxytocin.
    Inenaga K; Yamashita H
    J Physiol; 1986 Jan; 370():165-80. PubMed ID: 3007746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxytocin pretreatment enhances arginine vasopressin-induced motor disturbances and arginine vasopressin-induced phosphoinositol hydrolysis in rat septum: a cross-sensitization phenomenon.
    Poulin P; Pittman QJ
    J Neuroendocrinol; 1993 Feb; 5(1):33-9. PubMed ID: 8387375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arginine vasopressin and oxytocin increase intracellular calcium and cAMP in human glomerular epithelial cells in culture.
    Späth M; Pavenstädt H; Petersen J; Schollmeyer P
    Kidney Blood Press Res; 1996; 19(2):81-6. PubMed ID: 8871886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analogues of arginine vasopressin modified in position 2 or 3 with naphthylalanine: selective antagonists of oxytocin in-vitro.
    Sobocińska M; Lempicka E; Konieczna E; Derdowska I; Lammek B; Melhem S; Kozik W; Janecka J; Janecki M; Trzeciak HI
    J Pharm Pharmacol; 2000 Sep; 52(9):1105-12. PubMed ID: 11045891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats.
    Juif PE; Poisbeau P
    Pain; 2013 Aug; 154(8):1449-56. PubMed ID: 23707282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.